FindTrial
Sign In

One case of facial black spots caused by sustained-release methylphenidate hydrochloride tablets

One case of facial black spots caused by sustained-release methylphenidate hydrochloride tablets

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098825
Enrollment
Unknown
Registered
2025-03-13
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial black spots caused by the use of sustained-release methylphenidate hydrochloride tablets

Interventions

Stady case:NA

Sponsors

Tongde Hospital of Zhejiang Province
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
10 Years to 10 Years

Inclusion criteria

Inclusion criteria: NA

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Adverse drug reaction monitoring process;Prevention and treatment plan;—

Countries

China

Contacts

Public ContactWang Sensen

Tongde Hospital of Zhejiang Province

1185755941@qq.com+86 571 89972234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026